LF
IDXX icon

Lansforsakringar Fondforvaltning’s Idexx Laboratories IDXX Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6M Sell
25,927
-449
-2% -$288K 0.08% 212
2025
Q4 		$17.8M Sell
26,376
-83
-0.3% -$56.5K 0.09% 184
2025
Q3 		$16.9M Buy
26,459
+963
+4% +$585K 0.09% 193
2025
Q2 		$13.7M Sell
25,496
-1,545
-6% -$739K 0.08% 212
2025
Q1 		$11.4M Sell
27,041
-111
-0.4% -$48.2K 0.07% 245
2024
Q4 		$11.2M Buy
+27,152
New +$11.9M 0.06% 257

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lansforsakringar Fondforvaltning's IDXX Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q1 2026, selling an estimated $288K and leaving 25,927 shares worth $14.6M. The position accounts for 0.08% of the portfolio, ranked #212.

Lansforsakringar Fondforvaltning first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $17.8M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 25,927 shares of Idexx Laboratories worth $14.6M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 449 Idexx Laboratories shares in Q1 2026, an estimated $288K.
  • Idexx Laboratories made up 0.08% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #212 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Idexx Laboratories position peaked at $17.8M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.